Angiotensin-Neprilysin Inhibition and Left Ventricular Assist Device Therapy -Primary results of the multicENter, randomized, open-label, parallel group, study to evaluate the use of sacubitril/valsartan in HeartMate 3 LVAD recipients (ENVAD-HF)
{{output}}
Background: The role of heart failure specific therapies in LVAD recipients is unclear and observational data suggest improved outcomes with neurohormonal blockers. ENVAD-HF evaluated safety and tolerability of the Angiotensin-Ne... ...
